Molecular evolution of multiple recurrent cancers of the bladder

被引:83
作者
van Tilborg, AAG [1 ]
de Vries, A [1 ]
de Bont, M [1 ]
Groenfeld, LE [1 ]
van der Kwast, TH [1 ]
Zwarthoff, EC [1 ]
机构
[1] Erasmus Univ, Dept Pathol, NL-3000 DR Rotterdam, Netherlands
关键词
D O I
10.1093/hmg/9.20.2973
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We describe the reconstruction of bladder tumor development in individual patients spanning periods of up to 17 years. Genomic alterations detected in the tumors were used for hierarchical cluster analysis of tumor subclones. The cluster analysis highlights the clonal relationship between tumors from each patient. Based on the cluster date we were able to reconstruct the evolution of tumors in a genetic tree, where tumors with few aberrations precede those with many genetic insults. The sequential order of the tumors in these pedigrees differs from the chronological order in which the tumors appear. Thus, a tumor with few alterations can be occult for years following removal of a more deranged derivative. Extensive genetic damage is seen to accumulate during the evolution of the tumors. To explain the type and extent of genetic damage in combination with the low stage and grade of these tumors, we hypothesize that in bladder cancer pathogenesis an increased rate of mitotic recombination is acquired early in the tumorigenic process.
引用
收藏
页码:2973 / 2980
页数:8
相关论文
共 32 条
[1]   Evolution of neoplastic cell lineages in Barrett oesophagus [J].
Barrett, MT ;
Sanchez, CA ;
Prevo, LJ ;
Wong, DJ ;
Galipeau, PC ;
Paulson, TG ;
Rabinovitch, PS ;
Reid, BJ .
NATURE GENETICS, 1999, 22 (01) :106-109
[2]  
Bell SM, 1996, GENE CHROMOSOME CANC, V17, P108, DOI 10.1002/(SICI)1098-2264(199610)17:2<108::AID-GCC6>3.3.CO
[3]  
2-Q
[4]   Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas [J].
Cappellen, D ;
De Oliveira, C ;
Ricol, D ;
de Medina, SGD ;
Bourdin, J ;
Sastre-Garau, X ;
Chopin, D ;
Thiery, JP ;
Radvanyi, F .
NATURE GENETICS, 1999, 23 (01) :18-20
[5]  
Christensen M, 1998, INT J CANCER, V79, P396, DOI 10.1002/(SICI)1097-0215(19980821)79:4<396::AID-IJC15>3.3.CO
[6]  
2-D
[7]   BRCA2 germline mutations in male breast cancer cases and breast cancer families [J].
Couch, FJ ;
Farid, LM ;
DeShano, ML ;
Tavtigian, SV ;
Calzone, K ;
Campeau, L ;
Peng, Y ;
Bogden, B ;
Chen, Q ;
Neuhausen, S ;
ShattuckEidens, D ;
Godwin, AK ;
Daly, M ;
Radford, DM ;
Sedlacek, S ;
Rommens, J ;
Simard, J ;
Garber, J ;
Merajver, S ;
Weber, BL .
NATURE GENETICS, 1996, 13 (01) :123-125
[8]  
de Nooij-van Dalen AG, 1998, GENE CHROMOSOME CANC, V21, P30, DOI 10.1002/(SICI)1098-2264(199801)21:1<30::AID-GCC5>3.0.CO
[9]  
2-9
[10]   Molecular analysis of Fanconi anaemia [J].
Digweed, M ;
Sperling, K .
BIOESSAYS, 1996, 18 (07) :579-585